The Amyloid Proteins of Alzheimer's Disease as Potential Targets for Drug Therapy, Part 3
Claudio B. Caputa and Andre I. Salama
 Department of Pharmacology • ICI Pharmaceuticals Group • ICI Americas Inc. • Wilmington, DE 19897
Received 21 February 1989

References

  1. Abraham, C.R.; Selkoe, D.J.; Potter, H. Imunochemical identification of the serine protease inhibitor of 1-antichymotrysin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487-501;1998.
  2. Adiachi, N.; Koh, C.S.; Tsukada, N.; Shoji, S.; Yanagisawa, N. Invitro degradation of amyloid material by four proteases in tissue of a patient with familial amyloidotic polyneuropathy. J. Neurol. Sci. 84: 295-299; 1988.
  3. Anonymous. Alpha 1-PI. Drugs of Today. 24: 279; 1988.
  4. Anonymous. E-3123. Drugs of the Future. 13: 613-615; 1988.
  5. Bartus, R. T.; Dean, R L.; Beer, B.; Lippa, A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-417; 1982.
  6. Bondareff, W. Neurobiolog6y of Alzheimer's disease. Psychiatr. Annals 14: 179-184; 1984.
  7. Bowen, D. M.; Smith C. B.; White, P.; Davison, A. N. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459-495; 1976.
  8. Breathnach, S. M. Amyloid and amyloidosis. J. Am. Acad. Dermatol. 18: 1-16; 1988.
  9. Caputo, C. B.; MacCallum, D.K.; Kimura, J. H.; Schrode, J.; Hascall, V.C. Characterization of fragments produced by clostripain digestion of proteoglycans from the Swarm rat chondrosarcoma. Arch. Biochem. Biophys. 20: 220-233; 1980.
  10. Caputo, C. B.; Shaw, A. Osteroarthritis as a target for drug intervention, Ann. Reports Med. Chem. 22: 179-189; 1987.
  11. Caputo, C. B.; Sygowski, L. A.; Brunner, W. F.; Scott, C. W.; Salama, A. I. Propterties of several protein kinases that copurify with rat spinal cord neurofilaments. Biochim. Biophys. Acta; in press.
  12. Caputo, C. B.; Sygowski, L.A.; Patton, S.P.; Piehl, R.F.; Caccese. R. G.; DiPasquale, G. Degradation of cartilage-type proteoglycans by a neutral metalloprotease from rabbit chondrocytes. Connect. Tissue Res. 18: 191-203: 1988.
  13. Caputo, C. B.; Sygowski, L.A.; Patton, S.P. Wolanin, D.J.; DiPasquale, G. Protease inhibitors decrease cartilage degradation after meniscectomy. J. Orthop. Res. 6: 103-108; 1988.
  14. Caputo, C. B.; Sygowski, L. A.; Wolanin, D. J.; Patton, S.P.; Caccese R.G.; DiPasquale, G. Effect of synthetic metalloprotease inhibitors on cartilage autolysis in virtro. J. Pharmacol. Exp. Ther. 240: 460-465; 1987.
  15. Caputo, C.B.; Wolanin, D.J.;Roberts, R.A.; Sygowski, L.A.; Patton, S.P.; Caccese, R.G. Shaw, A.; diPasquale, G. Proteoglycan degradation by a chondrocyte metalloprotease: Effects of synthetic protease inhibitors. Biochem. Pharmacol. 36: 995-1002; 1987.
  16. Castano, E.M.; Frangione, B. Biology of disease. Human amyloidosis, Alzheimer disease and related disorder. Lab. Invest. 58: 122-132; 1988.
  17. Castano, E.M.;Ghiso, J.;Prelli, F.; Gorevic, P.D.;Migheli, A.;Frangione, B. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease B-Protein. Biochem. Biophys. Res. Commun. 41: 782-789.
  18. Chau, V.; Perry, G.; Friedman, R. Shaw, G. Ineffective turnover of abnormal proteins in Alzheimer's disease. Fed. Proc. 46: 21-146; 1987.
  19. Clark, A.; Parhad, I.;Schoel, M.; Bazett-Jones, D. Electron microscopic imaging (ESI) of phosphorous on neurofilaments (nf) and on paired helical filaments (PHF) of Alzheimer's disease (AD). Can J. Neurol. Sci. 14; 98-99; 1987.
  20. Cole. G.M.; Timiras, P.S. Ubiquitin-protein conjugates in Alzheimer's lesions. Neurosci. Lett. 79: 207-212; 987.
  21. Coria, F.; Castano, E.M.;Frangione, B. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease ß- Protein. Am. J. Pathol. 129: 422-428; 1987.
  22. Coria, F.; Castano, E.; Prelli, F.; Larrondo-Lillo, M.;Van Duinen, S.; Shelanski, M.L.; Frangione, B. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab. Invest. 58: 454-458; 1988.
  23. Cork. L.C.; Sternberger, N.H. Sternberger, L.A.; Casanova, M. F,; Struble, R.G.; Price, D.L. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 45: 56-64; 1986.
  24. Davies, P.; Maloney, A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet ii: 1403; 1976.
  25. Delabar, J. M.; Goldgaber, D.; Lamour, Y.; Nicole, A.; Huret, J. L.; de Grouchy, J.; Brown, P.; Gajdusek, D. C; Sinet, P.M. N-amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science 235; 1390-1392; 1987.
  26. Delabar, J.M.; Lamour, Y.; Gegonne, A.; Davous, P.; Roudier, M.; Nicole, A.;Ceballos, I.; Amouyel. P.; Stehelin, D.; Sinet, P.M. Rearrangement of Chromosome 21 in Alzheimer's disease. Ann. Genet. (Paris) 29: 226-228: 1986.
  27. Dynan, W. S.; Tjian. R. Control of eukaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins. Nature 316; 774-778; 1985.
  28. Epstein, W. V.; Tan. .; Wood. I.S. Formation of amyloid fibrils in vitro by action of human kidney lysosomal enzymes on Bence Jones proteins. J. Lab. Clin. Med 84: 108-110: 1974.
  29. Faltz. L.L.; Caputo, C.B.; Kimura, J.H.;Schrode, J.; Hascall, V. C. Structure of the complex between byaluronic acid, the hyaluronic acid binding region and the link protein of proteoglycan aggregates from the Swarm rat chondrosarcome. J. Biol. Chem. 254: 1381-1387; 1979.
  30. Fried, V.A.; Smith, H.T. Ubiquitin; Its association with specific cellular components and its active role in cellular events. Alheimer Disease Assoc. Disorders 2: 188; 1988.
  31. Furuya, H.; Saski, H.; Goto, I.; Wong, C.W.; Glenner, C.G.; Sakaki, Y. Amyloid ßProtein gene duplication is not common in Alzheimer's disease: Analysis by polymorphic restriction fragments. Biochem. Biophys. Res. Commun. 150: 75-81; 1988.
  32. Gandy, S.; Czerik, A.J.; Greengard, P. Phosphorylation of Alzheimer's disease amyloid precursor peptide by protein kinase C and Ca²/calmodulin-dependent protein kinase II. Proc. Natl. Acad. Sci. USA 85: 6218-6221; 1988.
  33. Ghiso, J.; Jensson, O.; Frangione, B. Amyloid fibrils in hereditary cerebral hemorrahage with amyloidosis of Icelandic type is variant of -trace basic protein (cystatin C). Proc. Natl. Acad. Sci. USA 83: 2974-2978; 1986.
  34. Ghiso, J.; Pon-Estel, B.; Frangione, B. Hereditary cerebral amyloid angiopathy; The amyloid fibrils contain a protein which is a variant of bystatin C, an inhibitor of lysosomal cysteine proteases. Biochem. Biophys. Res. Commun. 136: 548-554; 1986.
  35. Glenner, G.G. Amyloid deposits and amyloidosis. The ß-Fibrilloses (First of two parts). New Enlg. J. Med. 302: 1283-1292;1980.
  36. Glenner, G.G. Amyloid deposits and amylodosis. The ß-Fibrilloses (second of two parts). New Eng. J. Med. 302: 1333-1343; 1980.
  37. Glenner. G.G.; Eanes. E.D.; Page, D.L. Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science 174: 712-714;1971.
  38. Glenner, G.G.; Ein, D.; Eanes, E.D.; Bladen, H.A.; Terry, W.; Page, D.L. Creation of "amyloid" fibrils from Bence Jones proteins in Vitro. Science. 174: 712-714;1971.
  39. Glenner, G.G.; Wong, C.W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120: 885-890.
  40. Goedert, M.;Wischik, C.M.; Crowther, R.A.; Walker.J.E.; Klug, A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer's disease: Identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. USA 85: 4051-4055; 1988.
  41. Goldfinger, S.E. Colchicine for familial Mediterranean fever. New Engl. J. Med. 287: 1302; 1972.
  42. Goldgaber, D; Lerman, M.I; McBride, O.W.; Saffiotti, U.; Gajdusek, D.C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235; 877-880; 1987.
  43. Goldgaber, D.; Schmechel, D. E., Expression of the amyloid ß-Protein precursor gene. In: Wurtman, R.J.; Corkin, S.; Growdon, J.H.; Ritter-Walker, E.,eds. Proc. Fifth Meeting Internat. Study Group on Pharm. of Memory Disorders Assoc. with Aging. Cambridge, MA: Center for Brain Sciences and Metabolism Charitable Trust; 1989: 269-280.
  44. Goodchild, J.; Agrawal, S.; Civeira. M.P.; Sarin, P.S.; Sun. D.; Zamecnik, P.C. Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Pro. Natl. Acad. Sci. USA. 85; 5507-5511; 1988.
  45. Gottfries, C.G. Neurotransmitters in the brains of patients with dementia disorders. Dan. Med. Bull 32 (Suppl.1): 44-48; 1985.
  46. Green, P.J. ;Pines, O.; Inouye, M. The role of antisense RNA in gene regulation. Annu. Rev. Biochem. 55: 569-597; 1986.
  47. Green, S.; Chambon, P. Oestradiol induction of a glucocortioid-responsive gene by a chimaeric receptor. Nature 325: 75-78; 1987.
  48. Grunkdke-Iqbal. I.; Iqbal, K.; Quinlan, M.; Tung, Y.: C; Zaidi, M. S.; Wisniewski, H. M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261: 6084-6089; 1986.
  49. Grundke-Iqbal. I.; Iqbal,K.; Tung, Y.C.; Quinlan, M.; Wisniewski, H.M.; Binder, L. I. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83: 4913-4917;1986.
  50. Guiroy, D.C.; Miyazaki, M.; Multhaup, G.; Fischer, P.; Garruto, R.M.; Beyreuther, K.; Masters, C.L.; Simms, G.; Gibbs, C. J.; Gajdusek, D.C. Amyloid of neurofibrillary tangles of Guamanian parkinsonism-dementia and Alzheimer disease share identical amino acid sequence. Proc. Natl. Acad. Sci. USA 84: 2073-2077; 1987.
  51. Hamazaki, H. Ca2+-mediciated hemagglutination by serum amyloid P component and the inhibition by specific glycosaminoglycans. Biochem. Biophys.Res. Commun. 150: 212-218; 1988.
  52. Hamazaki, H. Calcium-mediated hemagglutination by serum amyloid P component and the inhibition by specific glycosaminoglycans. Biochem.Biophys. Res. Commun. 150: 212-218; 1988.
  53. Haugh, M.C.; Probst, A.; Ulrich, H.; Kahn, J.; Anderton, B.H. Alzheimer neurofibrillary tangles contain phosphorylated and hidden neurofilament epitopes. J. Neurol. Neurosurg. Psychiatry 49: 1213-1220; 1986.
  54. Helander, I.; Hopsu-Havu, V.K. Treatment of lichen amyloidosis by etretinate. Clin. Exp. Dermatol. 11: 574-577; 1986.
  55. Hirano, A.; Malamud, N.; Kurland, L.T. Parkinsonism-dementia complex, an endemic disease on the island of Guam. II.--Pathological features. Brain. 84: 662-679; 1961.
  56. Ihara,Y.; Nukina, N.; Miura, R.; Ogawara, M. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J. Biochem. 99: 1807-1820; 1986.
  57. Imahori, K.; Sugita, H.; Miyatake, T.; Ishihara, T.; Miyatani, N.; Kuwabara, T. Pharmacokinetics and safety of EST, a new thiol protease inhibitor in patients with muscle diseases. Jpn. J. Clin. Pharmacol. Ther. 16: 749-757; 1985.
  58. Isobe. T.; Osserman, E.F. Effects of dimethyl sulfoxide (DMSO) on Bence Jones proteins, amyloid fibrils and casein-induced amyloidosis. In.: Wegelius, O.; Pasternack, A.; Amyloidosis. New York: Academic Press; 1976: 247-257.
  59. Joachim. C.L.; Morris, J.H.; Kosik, K.S.; Selkoe, D.J. Tau antisera recognize neurofibrillary tangles in a range of neurodegenantive disorders. Ann. Neurol. 22: 514-520; 1987.
  60. Kalman, T.I. Enyme inhibition as a source of new drugs. Drug Dev. Res. 1: 311-328: 1981.
  61. Kang. J.; Lemaire, H.G.; Unterbeck, A.; Salbaum, J.M.: Masters, C.L.; Gzeschik, K.H.; Multhaup, G.; Beyreuther, K.; Muller-Hill, B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell- surface receptor. Nature. 325: 733-736; 1987.
  62. Kedar, I. Greenwald, M.; Ravid. M. Treatment of experimental murine amyloidosis with dimethyl sulfoxide. Eur. J. Clin. Invest. 7: 149-150; 1977.
  63. Khokha, R.; Denhardt. D.T. On the use of anti-sense RNA: down-regulation of mRNA encoding a metallo-proteinase inhibitor. Anticancer Res. 7: 653-660; 1987.
  64. Kirschner. D.A.; Abraham, C.; Selkoe, D. J. X-Ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer's disease indicates cross-ß conformation.. Proc. Nat. Acad. Sci. USA 83: 503-507: 1986.
  65. Kirschner, D.A.; Inouye. H. Duffy. L.K.; Sinclair, A: Lind, M.; Selkoe, D.J. Synthetic peptide homologous to ß protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA 84: 6953-6957; 1987.
  66. Kisilevsky, R. From arthritis to Alzheimer's disease: current concepts on the pathogenesis of amyloidosis. Can J. Physiol. Pharmacol. 65: 1805-1815; 1987.
  67. Kitaguchi, N.; Takahaski, Y.; Tokushima. Y.; Shiojiri, S.; Ito. H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 331: 530-532; 1988.
  68. Kosik, K. S.; Duffy, L.K.; Dowling, M.M.; Abraham, C.; McCluskey, A.; Selkoe, D.J. Microtubule-associated protein 2; Monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles. Proc. Natl. Acad. Sci. USA 81: 7941-7945; 1984.
  69. Linke, R.P.; Zucker-Franklin, D.; Franklin, E.C. Morphologic, chemical, and immonologic studies of amyloid-like fibrils formed from Bence-Jones proteins by proteolysis. J. Immunol. 111: 10-23; 1973.
  70. Man. D. M.A. The pathological association between Down Syndrome and Alzheimer disease. Mech. Aging. Dev. 43: 99-136; 1988.
  71. Mann. D.M.A.; Bonshek, R.E.; Marcyniuk, B.; Stoddart, R.W.; Torgerson, E. Saccarides of senile plaque and neurofibrillary tangles in Alzheimer's disease. Neurosci. Lett. 85: 277-282; 1988.
  72. Mann. D.M.A.; Hardy, J. The importance of altered structural proteins in the pathogenesis of Alzheimer's disease. Neurobiol. Aging. 7: 444-446; 1986.
  73. Masters, C.L.; Beyreuther, K. Protein abnormalities in neurofibrillary tangles; their relationship to the extracellular amyloid deposits of the A4 protein in Alzheimer's disease. In: Wurtman, R.J.; Corkin, S.;Growdon, J.H.; Ritter-Walker. E., eds. Proc. Fifth Meeting Internat. Study Group on Pharm. of Memory Disorders Assoc. with Aging. Cambridge, MA: Center for Brain Sciences and Metabolism Charitable Trust: 1989: 235-268.
  74. Masters.; C.L.; Multhaup. G.; Pottgiesser, J.; Martins, R.N.; Beyreuther, K. Neuronal origin of a cerebral amyloid; neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 4: 2757-2763; 1985.
  75. Masters. C.L.; Simms, G.; Weinman, N. A.; Multhaup, G.; McDonald, B.L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82: 4245-4249; 1985.
  76. Matsukura, M.; Shinozuka, K.; Zon, G.; Mitsuya. H.; Reitz, M.; Cohen, J.S.; Broder, S. Phosphorothioate analogs of oligodeoxy-nucleotides; Inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 84: 7706-7710; 1987.
  77. Matus. A.; Green, G.D.J. Age-related increase in cathepsin D like protease that degrades brain microtubule-associated proteins. Biochemistry. 26: 8083-8086; 1987.
  78. Mesulam. M. --M. Shift in patterns of cerebrocortical cholinesterases in Alzheimer's disease: Implications for pathogenesis, diagnosis, and treatment. In: Wurtman R.J. Corkin, S.; Growdon, J.H.; Ritter-Walker, E. eds. Proc. Fifth Meeting Internat. Study Group on Pharm. Of Memory Disorders Assoc. with Aging. Cambridge, MA: Center for Brain Sciences and Metabolism Charitable Trust; 1989: 373-378.
  79. Miller, C.C.J.; Anderton, B.H. Transglutaminase and the neuronal cytoskeleton in Alzheimer's disease. J. Neurochem. 46: 1912-1922: 1986.
  80. Mitsuya, H.; Jarrett, R.F.; Matsurkura, M.; Veronese. F.D.; DeVico, A.L.; Sarngadharan, M.G.; Johns, D.G.; Reitz, M.S.; Broder, S. Long- term inhibition of human T-lymphotropic virus type III/lymphadnenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2', 3' -dideoxynucleosides in vitro. Proc. Natl. Acad. Sci. USA 84: 2033-2037; 1987.
  81. Miyahara, T.; Shimojo; S.; Toyohara, K.; Imai, T.; Miyajima, M.; Honda, H.; Kamegai, M.; Ohzeki, M.; Kokatsu, J. Phase I study of EST, a new thiol protease inhibitor--The second report: Safety and pharmacokinetics in continuous administration. Jpn. J. Clin. Pharmacol. Ther. 16: 537-546; 1985.
  82. Mobley. W.C.; Neve, R.L.; Prusiner, S.B.; McKinley, M.P. Nerve growth factor increases mRNA levels for the prior protein and the B-Amyloid protein precursor in developing hamster brain. Proc. Natl. Acad. Sci. USA 85: 9811-9815; 1988.
  83. Neve. R.L. Selkoe, D.J.; Kurnit, D.M.; Kosik. K.S. A cDNA for a human microtubule associated protein 2 epitope in the Alzheimer neurofibrillary tangle. Mol. Brain. Res. 1: 193-196; 1986.
  84. Nukina, N. Ihara. Y. One of the antigenic determinants of paired helical filaments is related to tau protein. J. Biochem. 99: 1541-1544; 1986.
  85. Nukina, N.; Kosik. K.S.; Selkoe, D.J. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. Proc. Natl. Acad. Sci. USA 84: 3415-3419; 1987.
  86. Perry. E.K.; Perry, R.H.; Blessed. G.; Tomlinson, B.E. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1: 189; 1977.
  87. Perry, E.K.; Tomlinson, B.E.; Blessed, G.; Bergmann, K.; Gibson, P.H.; Perry, R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2: 1457-1459; 1978.
  88. Petrillo. E.W.; Ondetti. M. A. Angiotensin-converting enzme inhibitors; Medicinal chemistry and biological actions. Med. Res. Rev. 2: 1-41; 1982.
  89. Podisny, M.B. Lee, G.; Selkoe, D.J. Gene dosage of the amyloid ß precursor protein in Alzheimer's disease. Science 238: 669-672.
  90. Ponte, P.: Gonzalez-DeWhitt, P.; Schilling, J.; Miller; Hsu, D.; Greenberg, B,; Davis, K.; Wallace,; W.; Lieberburg, I.; Fuller, F.;Corderll, B. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 331: 525-527; 1988.
  91. Prelli, F.; Castano, E.; Glenner, G. G.; Frangione, B. Differences between vascular and plaque core amyloid in Alzheimer's disease. J. Neurochem. 51: 648-651; 1988.
  92. Prelli, F.; Castano, E.M.; Van Duinen, S.G.; Bots, G.T.A.M.; Luyendijk, W.; Frangione, B. Different processing of Alzheimer's B-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type. Biochem. Biophys. Res. Commun. 151: 1150-1155; 1988.
  93. Probst. A.; Brunnschweiler, H.; Lautenschlager, C.; Ulrich, J.A. special type of senile plaque, possibly an initial stage. Acta Neuropathol. (Berl) 74;133-141; 1987.
  94. Ravid, M.; Robson, M.; Kedar, I. Prolonged colchicine treatment in four patients with amyloidosis. Ann. Intern. Med. 87: 568-570; 1977.
  95. Robakis, N.K.; Ramakrishna, N.; Wolfe, G.; Wisniewski, H.M. Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc. Natl. Acad. Sci; USA 84: 4190-4194; 1987.
  96. Roses, A.D.; Pericak-Vance, M.A.; Haynes, C.S.; Haines, J.L.; Gaskell, P.A.; Yamaoka, L.; Hung, W-Y.; Heyman, A.L.; Clark, C.M. Linkage analysis in late onset familial Alzheimer's disease (AD). Ninth International Workshop on Human Gene Mapping. Cytogenet. Cell Genet. 46: 684; 1987.
  97. Roth. M. The association of clinical and neurobiological findings and its bearing on the classification and etiology of Alzheimer's disease. Br.Med. Bull. 42: 42-50; 1986.
  98. Seitoh, T.; Hansen, L.A.; Dobkins, K.R.; Terry, R. D. Increase Mr 60,000 protein phosphorylation is correlated with neocortical neurofibrillary tangles in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 47: 1-8; 1988.
  99. Salbaum, J.M.; Weidmann, A.; Lemaire, H.G.; Masters, C.L.; Beyreuther, K. The promotor of Alzheimer's disease amyloid--A4 precursor gene. EMBO J. 7;502-502; 1986.
  100. Saper, C.B. Which came first, the neuritic plaque or the neurofibrillary tangle? Neurobiol. Agineg 7: 502-503; 1986.
  101. Saper, C.B. German, D.C.; White. C.L. Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer type: Possible role in cell loss. Neurology 35: 1089-1095; 1985.
  102. Sashida, H.; Abiko, Y. Inhibition by NCO-700, a protease inhibitor of degradation of cardiac myofibrillar proteins during ischemia in dogs. Biochem. Pharmacol. 34: 3875-3889; 1985.
  103. Sayre, L.M.; Autilio-Gambetti, L.; Gambetti, P. Pathogenesis of experimental giant neurofilamentous axonopathies: A unified hypothesis based on chemical modification of neurofilaments. Brain Res. Rev. 10: 69-83; 1985.
  104. Schellenber, G.D.; Bird, T.D.; Wijsman, E.M.; Moore, D.K.; Boehnke, M.; Bryant, E.M.; Lampe, T.H.; Nochlin, D.; Sumi, S. M. Deeb, S.S.; Beyreuther, K.; Martin, G.M. Absence of linkage of chromosome 21q21 markers of familial Alzheimer's disease. Science 241;157-1510. 1988.
  105. Schubert, D.; Schroeder, R.; LaCorbiere, M.; Saitoh, T.; Cole, G. Amyloid B protein precursor is possibly a heparan sulfate proteoglycan core protein. Science 241: 223-226; 1988.
  106. Scott, C.W.; Salama, A.I.; Caputo, C.B. Phosphorylation of tau protein by glycogen synthase kinase-3. Fed. Proc. in press.
  107. Seldoe, D.J. Altered structural proteins and tangles; What do they tell us about the biology of Alzheimer's disease: Neurobio. Aging 7: 425-431; 1986.
  108. Selkoe, D.J. Deciphering Alzheimer's disease: the pace quickens. Trends Neurosci, 10: 181-184; 1987.
  109. Selkoe, D.J.; Abraham, C.; Ihara, Y. Brain transglutaminase: In vitro crosslinking of human neurofilament protein into insoluble polymer. Proc. Natl. Acad. Sci. USA 79: 6070-6074; 1982.
  110. Selkoe, D.J.; Ihara, Y.; Salazar, F.J. Alzheimer's disease: Insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Science 215: 1243-1245; 1982.
  111. Selkoe, D.J.; Podlisny, M.B.; Gronbeck, A.; Mammen, A.; Kosik. K.S. Molecular relation of amyloid filaments and paired helical filaments in Alzheimer's disease. In: Wurtman, R. J.; Corkin, S.; Growdon. J.H.; Ritter-Walker. E. eds.. Proc. Fifth Meeting Internat. Study Group on Pharm. Of Memory Disorders Assoc. with Aging. Cambridge, MA: Center for Brain Sciences and Metabolism Charitable Trust; 1989: 281-296.
  112. Shirhama, T.; Benson, MD; Cohen, A.S. Tanaka, A. Fibrilllar assemblage of variable segments of immunoglobulin light chains: an electron microscopic study. J. Immunol. 10;21-30; 1973.
  113. Skinner, M. Stone, P.; Shirhama, T.; Connors, L.H.; Calore, J.; Cohen, A.S. The association of an elastase with amyloid fibrils. Proc Soc. Biol. Med 181;211-214; 1986.
  114. Smith, C. C.; Aurelian, L.; Reddy, M.P.; Miller, P.S.; Ts'o, P. O. P. Antiviral effect of an oligo (nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. Proc. Natl. Scie. USA. 83: 2787-2791; 1986.
  115. Snow. A.D.; Willmer. J.: Kisilevsky, R. Sulfated glycosaminoglycans; A common constituent of all amyloids? Lab. Inves. 56: 120-123; 1987.
  116. Snow. A.D.; Willmer, J. P.; Kisilevsky, R. Sulfated glysaminoglycans in Alzheimer's disease. Hum. Pathol. 18: 506-510; 1987.
  117. St. George-Hyslop, P.H.; Tanzi, R.E.; Polinsky, R.J. Neve, R. L. et.al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235: 885-890; 1987.
  118. St. George-Hyslop, P.H.; Tanzi, R. E.; Polinsky R.J. Neve, R. L., et. al. Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease. Science 238: 664-666; 1987.
  119. Sternberger, N.H.; Sternberger, L.A.; Ulrich, J. Aberrant neurofilament phosphorylation in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 82: 274-276; 1985.
  120. Struble. R.G.; Hedreen, J.C.; Cork.; L.C.; Price, D.L. Acetylcholinesterase activity in senile plaques of aged macques. Neurobiol. Aging 5: 191-198; 1984.
  121. . Struhl. K. Promoters, activator proteins, and the mechanism of transcriptional initiation in yeast. Cell 49: 295-297; 1987.
  122. Sumpter, P.Q.; Mann. D.M.A.; Davies, C.A.; Yates, P.O.; Snowden, J.S.; Neary, D. An ultrastructural analysis of the effects of the cerebral cortex in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 12: 305-319; 1986.
  123. Suzuki, H.; Takeda, M.; Kato, Y.; Yamashita, T.; Tada, K.; Hariguchi, S.; Nishimura, T. Cathepsin D activities in dementia brains and the degradation of neurofilament proteins with cathepsin D. Neurochem. Res. 13: 264; 1988.
  124. Tanzi, R.E.; Gusella, J.F.; Watkins, P.C.; Bruns, G.A.P.; St. George-Hyslop, P.; Van Keuren, M.L.; Patterson, D.; Pagen, S.; Kurnit, D.M.; Neve, R.L. Amyloid B protein gene is not duplicated in brains from patients with Alzheimer's disease. Science 238: 666-669; 1987.
  125. Tanzi, R. E.; Gusella, J. F.; Watkins, P.C.; Burns, G.A.P.; St. George-Hyslop, P.; Van Keuren, M. L.; Patterson, D.; Pagan, S.; Kurnit, D. M.; Neve, R. L. Amyloid ß protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235: 880-884; 1987.
  126. Tanzi, R.E.; Mc Clatchey, A. I.; Lamperti, E. D.; Villa-Komaroff, L.; Gusella, J. F.; Neve, R. L. Protease inibitor domain encoded by any amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331: 528-530; 1988.
  127. Tanzi, R. E.; St. George-Hyslop. P. H.; Haines, J. L.; Polinsky, R. J., et al. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid B-protein gene. Nature 329: 156-157; 1987.
  128. Tape, C.; Tan, R.; Nesheim. M.; Kisilevsky, R. Is proteolytic attack on amyloid precursor proteins a pre or post fibrilogenic event? Lab. Invest. 58: 92A; 1988.
  129. Terry, R. D.; Hansen, L..A.; DeTeresea, R.; Davies, P.; Tobias, H.; Katzman, R. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 46: 262-268; 1987.
  130. Tomlinson. B.E. Plaques, tangles, and Alzheimer's disease. Psychol. Med. 12: 449-459; 1982.
  131. Van Broeckhoven. C.; Genthe, A. M.; Vandenberghe, A.; Horsthemke, B., et al. Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families. Nature 329: 153-155; 1987.
  132. Van Duinen. S. G.; Castano, E. M.; Prelli, F. Bots. G. T. A. B.; Luyendijk, W.; Frangione, B. Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc. Natl. Acad. Sci. USA. 84: 5991-5994; 1987.
  133. . Wharton. R. P.; Brown, E. L.; Ptashne, M. Substituting an a-helix switches the sequence-specific DNA interactions of a repressor. Cell 38: 361-369; 1984.
  134. . Wharton, R. P. ; Ptashne, M. Changing the binding specificity of a repressor by redesigning an a-helix. Nature 316: 601-605; 1985.
  135. Wilcock, G. K. Esiri, M. M. Plaques, tangles, and dementia. A quantitative study. J. Neurol. Sci. 56: 343-356; 1982.
  136. Wischik, C. M.; Novak, M.; Edwards, P. C.; Klug, A.; Tichelaar. W.; Crowther, R. A. Structural characterization of the core of the paired helical filament of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 85: 4884-4888; 1988.
  137. Wischik, C. M.; Novak, M.; Thogersen, H,C.; Edwards, P. C.; Runswichk, M. J.; Jakes, R.; Walker, J. E.; Milstein, C.; Roth, M.; Klug. A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 85: 4506-4510; 1988.
  138. Wisniewski, H. M.; Currie, J. R.; Barcikowska, M.; Robakis, N. K.; Miller, D. L. Alzheimer's disease, a cerebral form of amyloidosis. In: Pouplard-Bartelaix. A.; Emile, J.; Christen, Y., eds. Immunology and Alzheimer's disease. Paris: Springer-Verlag; 1988;1-6.
  139. Wisniewski, H. M.; Sinatra, R. S.; Iqbal, K., Grundke-Iqbal, I. Neurofibrillary and synaptic pathology in the aged brain. In: Johnson. J. E., Jr., ed. Aging and cell structure, vol. 1. New York; Plenum Publishing corp: 1981: 105-141.
  140. . Woog, C. W.; Quaranta, V.; Glenner, G. G. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc. Natl. Acad. Sci. USA 82: 8729-8732; 1985.
  141. Wood, J.G.; Mirra, S. S.; Pollack, N. J. Binder, L. I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau, (t). Proc. Natl. Acad. Sci. USA 83: 4040-4043; 1986.
  142. Yanker, B. A.; Dawes, L. R.; Fisher, S.; Villa-Komaroff, L.; Granite, M.L.; Neve, R. L. Neurotoxicity of a fragment of the precursor associated with Alzheimer's disease. Science417-140.1989.
  143. S. H.; Dickson. D. W.; Crowe. A.; Butler, M,; Shelanski, M. L. Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule assoicated proteins tau and MAP 2. Am J. Pathol. 126: 81-91; 1987.
  144. Yen, S. H.; Gaskin, F.; Fu, S. M. Neurofibrillary tangles in senile dementia of the Alzheimer's type share an antigenic determinant with intermediate filaments of the vimentin class. Am. J. Pathol. 113: 373-381; 1983.
  145. Young. I. D.; Kisilevsky, R. Ultrastructural localization of glycosaminoglycans in amyloid deposits of Alzheimer's disease. Lab. Invest. 58: 107A;1988.
  146. Zappia. V.; Galletti, P.; Porta, R.; Wold, F. Advances in posttranslational modifications of proteins and aging. New York: plenum Press; 1988. (Adv. Exp. Med. Biol. vol. 231).
  147. . Zebrower, M.; Beeber, C.; Kieras. F. J. Proteoglycan synthesis in Alzheimer's disease fibroblasts. Age 10: 164; 1987.
  148. Zhang, H.; Sternberger, N.; Herman, M.; Robinstein, L.; Binder, L.; Sternberger, L. Abnormal processing of multiple proteins in Alzheimer's disease (AD). J. Neuropathol. Exp. Neurol. 47: 319;1988.

Source: This article was printed in "Microbiology of Aging, Vol. 10, pp. 451-461. ŠPergamon Press pic. 1989. Permission was granted by the publisher to transcribe this article for the Internet by DMSO Organization. Copyright is retained by the publisher. No part of this article may be reprinted without written authorization from the publisher.
 
© 2001-2022 All rights reserved